9 meters biopharma, inc. (INNT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15Dec'14
Assets
Current assets:
Cash and cash equivalents

2,667

4,592

8,863

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

13,337

11,494

5,728

8,111

10,663

12,976

355

174

39

150

1,453

2,970

152

119

97

Restricted deposit

75

75

75

75

75

75

-

-

-

0

-

-

-

-

-

-

-

-

Accounts receivable, net of allowances of $271 and $253, respectively

-

-

-

-

-

-

-

-

-

-

127

214

817

856

928

1,038

644

3,569

Inventories

-

-

-

-

-

-

-

-

-

-

498

607

638

1,105

1,789

1,029

633

2,587

Prepaid expenses and other current assets

488

555

781

1,117

803

504

525

244

250

161

257

325

421

619

440

54

141

68

Trademark

-

-

-

-

-

-

-

-

-

-

2,319

2,351

2,384

2,417

2,450

2,483

2,548

0

Deferred offering costs

-

-

0

0

100

104

0

0

0

159

-

-

-

-

0

1,154

619

48

Due from related party

-

-

-

-

-

-

0

0

0

75

-

-

-

-

-

-

-

-

Total current assets

3,230

5,222

9,719

14,530

12,472

6,413

8,637

10,907

13,227

752

1,056

1,185

2,026

4,033

6,127

2,273

1,537

6,321

Property and equipment, net

20

25

28

34

29

35

40

45

51

40

-

-

-

-

-

-

-

-

Operating Lease, Right-of-Use Asset

28

42

56

69

81

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

5

5

5

5

5

5

5

5

5

5

-

-

-

-

-

-

-

-

Deposits and other assets

-

-

-

-

-

-

-

-

-

-

14

14

14

14

14

14

14

42

Total assets

3,285

5,296

9,810

14,639

12,590

6,454

8,683

10,958

13,285

798

3,389

3,550

4,424

6,464

8,591

5,924

4,718

6,411

Liabilities and Stockholders’ Deficit
Current liabilities:
Line of credit

-

-

-

-

-

-

-

-

-

-

107

-

-

-

0

322

215

5,051

Accounts payable

5,075

3,890

3,056

2,712

3,928

3,618

2,882

3,347

2,024

2,658

624

599

667

268

388

1,466

1,021

1,613

Accrued Liabilities, Current

4,847

4,747

1,863

974

897

826

229

0

5

1,180

1,506

1,416

1,473

1,786

3,275

3,628

3,311

4,198

Convertible notes payable, net

4,302

3,184

3,875

4,044

3,736

5,196

0

0

0

8,329

-

-

-

-

-

-

-

-

Customer refund

-

-

-

-

-

-

-

-

-

-

1,336

1,336

1,225

1,840

1,840

1,825

1,850

0

Due to related parties

-

-

-

-

-

-

-

-

-

-

34

34

34

44

0

534

510

502

Convertible note payable

-

-

-

-

-

-

5,190

4,151

3,407

0

1,270

378

38

38

38

4,392

3,505

35

Derivative liabilities

440

408

770

999

1,180

370

-

-

-

0

-

-

-

-

-

-

-

-

Warrant liabilities

1,058

2,637

3,188

660

1,113

0

-

-

-

-

-

-

-

-

-

-

-

-

Convertible promissory notes, related party, net

-

-

-

-

-

-

0

0

0

244

-

-

-

-

-

-

-

-

Accrued interest

81

0

314

174

35

101

0

0

0

560

-

-

-

-

-

-

-

-

Lease liability, current portion

28

42

56

54

53

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

15,835

14,910

13,125

9,618

10,943

10,113

8,302

7,499

5,438

12,973

4,877

3,763

3,437

3,976

5,541

12,167

10,412

11,399

Lease liability, net of current portion

-

-

-

14

28

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

-

-

-

9,633

10,972

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Stockholders’ deficit:
Preferred stock $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

-

-

-

0

0

0

0

0

0

0

0

0

Common stock - $0.0001 par value, 350,000,000 shares authorized; 41,324,976 and 39,477,667 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

4

3

3

3

3

2

2

2

2

11

1

1

1

1

0

0

0

0

Additional paid-in capital

61,613

60,946

58,341

57,441

49,565

39,854

40,879

43,181

43,353

7,167

35,986

35,753

35,315

34,575

33,880

22,753

20,181

12,146

Accumulated deficit

-74,167

-70,564

-61,660

-52,438

-47,950

-43,515

-40,500

-39,724

-35,509

-19,353

-37,475

-35,967

-34,329

-32,088

-30,830

-28,996

-25,875

-17,134

Total stockholders’ deficit

-12,550

-9,614

-3,314

5,006

1,617

-3,659

380

3,459

7,846

-12,174

-1,488

-213

987

2,488

3,050

-6,243

-5,694

-4,988

Total liabilities and stockholders’ deficit

3,285

5,296

9,810

14,639

12,590

6,454

8,683

10,958

13,285

798

3,389

3,550

4,424

6,464

8,591

5,924

4,718

6,411